Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension.

Zhang J, Dong J, Martin M, He M, Gongol B, Marin TL, Chen L, Shi X, Yin Y, Shang F, Wu Y, Huang HY, Zhang J, Zhang Y, Kang J, Moya EA, Huang HD, Powell FL, Chen Z, Thistlethwaite PA, Yuan ZY, Shyy JY.

Am J Respir Crit Care Med. 2018 Aug 15;198(4):509-520. doi: 10.1164/rccm.201712-2570OC.

2.

Needle localization of small pulmonary nodules: Lessons learned.

Thistlethwaite PA, Gower JR, Hernandez M, Zhang Y, Picel AC, Roberts AC.

J Thorac Cardiovasc Surg. 2018 May;155(5):2140-2147. doi: 10.1016/j.jtcvs.2018.01.007. Epub 2018 Jan 17.

PMID:
29455962
3.

Linking Vascular Remodeling and Inflammation in Pulmonary Arterial Hypertension: Is There a Common Root Cause?

Thistlethwaite PA.

Am J Respir Cell Mol Biol. 2017 Jul;57(1):15-17. doi: 10.1165/rcmb.2017-0102ED. No abstract available.

4.

In vitro initial stability of a stemless humeral implant.

Favre P, Seebeck J, Thistlethwaite PA, Obrist M, Steffens JG, Hopkins AR, Hulme PA.

Clin Biomech (Bristol, Avon). 2016 Feb;32:113-7. doi: 10.1016/j.clinbiomech.2015.12.004. Epub 2015 Dec 21.

PMID:
26747397
5.

Multifocal Endobronchial Fibromas Presenting as Unilobar Emphysema.

Mumtaz S, Alkhuziem M, Chow J, Yen A, Lin G, Harrell JH, Thistlethwaite PA.

Ann Thorac Surg. 2015 Sep;100(3):1109-11. doi: 10.1016/j.athoracsur.2014.11.011.

PMID:
26354646
6.

Response to Letter Regarding Article, "The ERG-APLNR Axis Controls Pulmonary Venule Endothelial Proliferation in Pulmonary Veno-Occlusive Disease".

Lathen C, Zhang Y, Chow J, Singh M, Lin G, Nigam V, Ashraf YA, Yuan JX, Robbins IM, Thistlethwaite PA.

Circulation. 2015 Jul 14;132(2):e17. doi: 10.1161/CIRCULATIONAHA.114.014783. No abstract available.

7.

Invited commentary.

Thistlethwaite PA.

Ann Thorac Surg. 2015 Mar;99(3):1038-9. doi: 10.1016/j.athoracsur.2015.01.002. No abstract available.

PMID:
25742824
8.

Notch Activation of Ca(2+) Signaling in the Development of Hypoxic Pulmonary Vasoconstriction and Pulmonary Hypertension.

Smith KA, Voiriot G, Tang H, Fraidenburg DR, Song S, Yamamura H, Yamamura A, Guo Q, Wan J, Pohl NM, Tauseef M, Bodmer R, Ocorr K, Thistlethwaite PA, Haddad GG, Powell FL, Makino A, Mehta D, Yuan JX.

Am J Respir Cell Mol Biol. 2015 Sep;53(3):355-67. doi: 10.1165/rcmb.2014-0235OC.

9.

ERG-APLNR axis controls pulmonary venule endothelial proliferation in pulmonary veno-occlusive disease.

Lathen C, Zhang Y, Chow J, Singh M, Lin G, Nigam V, Ashraf YA, Yuan JX, Robbins IM, Thistlethwaite PA.

Circulation. 2014 Sep 30;130(14):1179-91. doi: 10.1161/CIRCULATIONAHA.113.007822. Epub 2014 Jul 25.

10.

Invited commentary.

Thistlethwaite PA.

Ann Thorac Surg. 2014 Jun;97(6):2025-6. doi: 10.1016/j.athoracsur.2014.03.033. No abstract available.

PMID:
24882285
11.

Activation of Notch signaling by short-term treatment with Jagged-1 enhances store-operated Ca(2+) entry in human pulmonary arterial smooth muscle cells.

Yamamura H, Yamamura A, Ko EA, Pohl NM, Smith KA, Zeifman A, Powell FL, Thistlethwaite PA, Yuan JX.

Am J Physiol Cell Physiol. 2014 May 1;306(9):C871-8. doi: 10.1152/ajpcell.00221.2013. Epub 2014 Feb 26.

12.

Transcriptome sequencing of tumor subpopulations reveals a spectrum of therapeutic options for squamous cell lung cancer.

Barrett CL, Schwab RB, Jung H, Crain B, Goff DJ, Jamieson CH, Thistlethwaite PA, Harismendy O, Carson DA, Frazer KA.

PLoS One. 2013;8(3):e58714. doi: 10.1371/journal.pone.0058714. Epub 2013 Mar 20.

13.

Invited commentary.

Thistlethwaite PA.

Ann Thorac Surg. 2013 Mar;95(3):1033-4. doi: 10.1016/j.athoracsur.2012.12.008. No abstract available.

PMID:
23438530
14.

Invited commentary.

Thistlethwaite PA.

Ann Thorac Surg. 2011 Apr;91(4):1213. doi: 10.1016/j.athoracsur.2011.01.066. No abstract available.

PMID:
21440147
15.

Invited commentary.

Thistlethwaite PA, Jamieson SW.

Ann Thorac Surg. 2011 Apr;91(4):1100. doi: 10.1016/j.athoracsur.2011.01.006. No abstract available.

PMID:
21440130
16.

Surgical management of endobronchial inflammatory myofibroblastic tumors.

Thistlethwaite PA, Renner J, Duhamel D, Makani S, Lin GY, Jamieson SW, Harrell J.

Ann Thorac Surg. 2011 Feb;91(2):367-72. doi: 10.1016/j.athoracsur.2010.09.017.

PMID:
21256271
17.

Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension.

Aldred MA, Comhair SA, Varella-Garcia M, Asosingh K, Xu W, Noon GP, Thistlethwaite PA, Tuder RM, Erzurum SC, Geraci MW, Coldren CD.

Am J Respir Crit Care Med. 2010 Nov 1;182(9):1153-60. doi: 10.1164/rccm.201003-0491OC. Epub 2010 Jun 25.

18.

Notch signaling in pulmonary hypertension.

Thistlethwaite PA, Li X, Zhang X.

Adv Exp Med Biol. 2010;661:279-98. doi: 10.1007/978-1-60761-500-2_18. Review.

PMID:
20204737
19.

Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice.

Huang C, Zhang X, Ramil JM, Rikka S, Kim L, Lee Y, Gude NA, Thistlethwaite PA, Sussman MA, Gottlieb RA, Gustafsson AB.

Circulation. 2010 Feb 9;121(5):675-83. doi: 10.1161/CIRCULATIONAHA.109.902221. Epub 2010 Jan 25.

20.

Notch3 signaling promotes the development of pulmonary arterial hypertension.

Li X, Zhang X, Leathers R, Makino A, Huang C, Parsa P, Macias J, Yuan JX, Jamieson SW, Thistlethwaite PA.

Nat Med. 2009 Nov;15(11):1289-97. doi: 10.1038/nm.2021. Epub 2009 Oct 25.

21.

Inhibition of mTOR attenuates store-operated Ca2+ entry in cells from endarterectomized tissues of patients with chronic thromboembolic pulmonary hypertension.

Ogawa A, Firth AL, Yao W, Madani MM, Kerr KM, Auger WR, Jamieson SW, Thistlethwaite PA, Yuan JX.

Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L666-76. doi: 10.1152/ajplung.90548.2008. Epub 2009 Jul 24.

22.

Development and pathology of pulmonary hypertension.

Tuder RM, Abman SH, Braun T, Capron F, Stevens T, Thistlethwaite PA, Haworth SG.

J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S3-9. doi: 10.1016/j.jacc.2009.04.009. Review.

23.

Cellular and molecular basis of pulmonary arterial hypertension.

Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX, Weir EK.

J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S20-31. doi: 10.1016/j.jacc.2009.04.018. Review.

24.

Comparative biomechanical investigation of a modular dynamic lumbar stabilization system and the Dynesys system.

Gédet P, Haschtmann D, Thistlethwaite PA, Ferguson SJ.

Eur Spine J. 2009 Oct;18(10):1504-11. doi: 10.1007/s00586-009-1077-7. Epub 2009 Jun 30.

25.

A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension.

Yu Y, Keller SH, Remillard CV, Safrina O, Nicholson A, Zhang SL, Jiang W, Vangala N, Landsberg JW, Wang JY, Thistlethwaite PA, Channick RN, Robbins IM, Loyd JE, Ghofrani HA, Grimminger F, Schermuly RT, Cahalan MD, Rubin LJ, Yuan JX.

Circulation. 2009 May 5;119(17):2313-22. doi: 10.1161/CIRCULATIONAHA.108.782458. Epub 2009 Apr 20.

26.

Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension.

Yao W, Firth AL, Sacks RS, Ogawa A, Auger WR, Fedullo PF, Madani MM, Lin GY, Sakakibara N, Thistlethwaite PA, Jamieson SW, Rubin LJ, Yuan JX.

Am J Physiol Lung Cell Mol Physiol. 2009 Jun;296(6):L870-8. doi: 10.1152/ajplung.90413.2008. Epub 2009 Mar 13.

27.

Airway stenoses after lung transplantation: incidence, management, and outcome.

Thistlethwaite PA, Yung G, Kemp A, Osbourne S, Jamieson SW, Channick C, Harrell J.

J Thorac Cardiovasc Surg. 2008 Dec;136(6):1569-75. doi: 10.1016/j.jtcvs.2008.08.021.

28.

Technique and outcomes of pulmonary endarterectomy surgery.

Thistlethwaite PA, Kaneko K, Madani MM, Jamieson SW.

Ann Thorac Cardiovasc Surg. 2008 Oct;14(5):274-82. Review.

PMID:
18989242
29.

Invited commentary.

Thistlethwaite PA.

Ann Thorac Surg. 2008 Oct;86(4):1320. doi: 10.1016/j.athoracsur.2008.07.065. No abstract available.

PMID:
18805184
30.

Invited commentary. The apolipoprotein E epsilon4 allele.

Thistlethwaite PA.

Ann Thorac Surg. 2008 Sep;86(3):848. doi: 10.1016/j.athoracsur.2008.05.054. No abstract available.

PMID:
18721572
31.

Endothelial expression of bone morphogenetic protein receptor type 1a is required for atrioventricular valve formation.

Kaneko K, Li X, Zhang X, Lamberti JJ, Jamieson SW, Thistlethwaite PA.

Ann Thorac Surg. 2008 Jun;85(6):2090-8. doi: 10.1016/j.athoracsur.2008.02.027.

PMID:
18498827
32.

Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension.

Patel HH, Zhang S, Murray F, Suda RY, Head BP, Yokoyama U, Swaney JS, Niesman IR, Schermuly RT, Pullamsetti SS, Thistlethwaite PA, Miyanohara A, Farquhar MG, Yuan JX, Insel PA.

FASEB J. 2007 Sep;21(11):2970-9. Epub 2007 Apr 30.

PMID:
17470567
33.

Pulmonary artery smooth muscle cells from normal subjects and IPAH patients show divergent cAMP-mediated effects on TRPC expression and capacitative Ca2+ entry.

Zhang S, Patel HH, Murray F, Remillard CV, Schach C, Thistlethwaite PA, Insel PA, Yuan JX.

Am J Physiol Lung Cell Mol Physiol. 2007 May;292(5):L1202-10. Epub 2006 Dec 22.

34.

Molecular biology of chronic thromboembolic pulmonary hypertension.

Sacks RS, Remillard CV, Agange N, Auger WR, Thistlethwaite PA, Yuan JX.

Semin Thorac Cardiovasc Surg. 2006 Fall;18(3):265-76. Review.

PMID:
17185190
35.

Outcomes of pulmonary endarterectomy surgery.

Thistlethwaite PA, Madani M, Jamieson SW.

Semin Thorac Cardiovasc Surg. 2006 Fall;18(3):257-64.

PMID:
17185189
36.

Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes.

Thistlethwaite PA, Madani MM, Kemp AD, Hartley M, Auger WR, Jamieson SW.

Ann Thorac Surg. 2006 Dec;82(6):2139-45.

PMID:
17126125
37.
38.

Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1.

Murray F, Patel HH, Suda RY, Zhang S, Thistlethwaite PA, Yuan JX, Insel PA.

Am J Physiol Lung Cell Mol Physiol. 2007 Jan;292(1):L294-303. Epub 2006 Sep 15.

39.

Lung cancer and radiofrequency ablation.

Rose SC, Thistlethwaite PA, Sewell PE, Vance RB.

J Vasc Interv Radiol. 2006 Jun;17(6):927-51; quiz 951. Review.

PMID:
16778226
40.

Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension.

Thistlethwaite PA, Kemp A, Du L, Madani MM, Jamieson SW.

J Thorac Cardiovasc Surg. 2006 Feb;131(2):307-13. Epub 2006 Jan 18.

41.

Divergent effects of BMP-2 on gene expression in pulmonary artery smooth muscle cells from normal subjects and patients with idiopathic pulmonary arterial hypertension.

Fantozzi I, Huang W, Zhang J, Zhang S, Platoshyn O, Remillard CV, Thistlethwaite PA, Yuan JX.

Exp Lung Res. 2005 Oct;31(8):783-806. doi: 10.1080/01902140500461026.

42.

Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse.

Kido M, Du L, Sullivan CC, Li X, Deutsch R, Jamieson SW, Thistlethwaite PA.

J Am Coll Cardiol. 2005 Dec 6;46(11):2116-24. Epub 2005 Nov 9.

43.

Breaking the barriers to global gene delivery.

Weitzman MD, Thistlethwaite PA.

Nat Biotechnol. 2005 Mar;23(3):305-6. No abstract available.

PMID:
15765082
44.

Gene transfer of a TIE2 receptor antagonist prevents pulmonary hypertension in rodents.

Kido M, Du L, Sullivan CC, Deutsch R, Jamieson SW, Thistlethwaite PA.

J Thorac Cardiovasc Surg. 2005 Feb;129(2):268-76.

45.

Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension.

Yu Y, Fantozzi I, Remillard CV, Landsberg JW, Kunichika N, Platoshyn O, Tigno DD, Thistlethwaite PA, Rubin LJ, Yuan JX.

Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13861-6. Epub 2004 Sep 9.

46.

Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectors.

Du L, Kido M, Lee DV, Rabinowitz JE, Samulski RJ, Jamieson SW, Weitzman MD, Thistlethwaite PA.

Mol Ther. 2004 Sep;10(3):604-8.

47.

Bosentan inhibits transient receptor potential channel expression in pulmonary vascular myocytes.

Kunichika N, Landsberg JW, Yu Y, Kunichika H, Thistlethwaite PA, Rubin LJ, Yuan JX.

Am J Respir Crit Care Med. 2004 Nov 15;170(10):1101-7. Epub 2004 Aug 18.

PMID:
15317671
48.

Pulmonary thromboendarterectomy.

Thistlethwaite PA, Jamieson SW.

Ann Thorac Surg. 2004 Aug;78(2):746-7. No abstract available.

PMID:
15309813
49.

Pulmonary thromboendarterectomy surgery.

Thistlethwaite PA, Madani M, Jamieson SW.

Cardiol Clin. 2004 Aug;22(3):467-78, vii. Review.

PMID:
15302365
50.

Molecular biology of primary pulmonary hypertension.

Mandegar M, Thistlethwaite PA, Yuan JX.

Cardiol Clin. 2004 Aug;22(3):417-29, vi. Review.

PMID:
15302361

Supplemental Content

Loading ...
Support Center